Abstract
Alzheimers disease (AD) is characterized by the aggregation and subsequent deposition of misfolded β- amyloid (Aβ) peptide. The unfolded protein response (UPR) is activated by misfolded protein stress in the endoplasmic reticulum (ER). In previous studies we demonstrated mild activation of the UPR by extracellularly applied oligomeric but not fibrillar Aβ1-42. In addition, we showed that oligomeric Aβ1-42 is internalized by cells, whereas fibrillar Aβ1-42 remains on the outside of the cell. Inhibition of Aβ uptake specifically inhibits toxicity of Aβ1-42 oligomers, underscoring the toxic potential of intracellular Aβ. Therefore, in the present study, we investigated the connection between intracellularly produced Aβ and the ER stress response, using human neuroblastoma cells overexpressing either wild type APP695 (APPwt) or APP695V717F (APPmut). Both cell lines secrete higher levels of Aβ1-40 and Aβ1-42 compared to the parental line. In addition, APPmut produces more Aβ1-42 than APPwt. Whereas the basal levels of UPR markers are not different, we find augmented UPR induction in response to ER stress in both APP overproducing cell lines compared to the parental cell line, with the strongest UPR activation in APPmut cells. In addition, ER stress toxicity was highest in APPmut cells, strongly suggesting a connection with the production of Aβ1-42. The difference in ER stress mediated toxicity between the APPwt and APPmut cell lines is alleviated by pretreatment with γ-secretase inhibitor, indicating that it is dependent on Aβ production and in particular on Aβ1-42. Our data indicate that increased Aβ1-42 production sensitizes neuroblastoma cells for ER stress toxicity.
Keywords: Alzheimer's disease, β-Amyloid, intracellular, endoplasmic reticulum, unfolded protein response
Current Alzheimer Research
Title: Increased Aβ1-42 Production Sensitizes Neuroblastoma Cells for ER Stress Toxicity
Volume: 5 Issue: 5
Author(s): Sidhartha M. Chafekar, Rob Zwart, Robert Veerhuis, H. Vanderstichele, Frank Baas and Wiep Scheper
Affiliation:
Keywords: Alzheimer's disease, β-Amyloid, intracellular, endoplasmic reticulum, unfolded protein response
Abstract: Alzheimers disease (AD) is characterized by the aggregation and subsequent deposition of misfolded β- amyloid (Aβ) peptide. The unfolded protein response (UPR) is activated by misfolded protein stress in the endoplasmic reticulum (ER). In previous studies we demonstrated mild activation of the UPR by extracellularly applied oligomeric but not fibrillar Aβ1-42. In addition, we showed that oligomeric Aβ1-42 is internalized by cells, whereas fibrillar Aβ1-42 remains on the outside of the cell. Inhibition of Aβ uptake specifically inhibits toxicity of Aβ1-42 oligomers, underscoring the toxic potential of intracellular Aβ. Therefore, in the present study, we investigated the connection between intracellularly produced Aβ and the ER stress response, using human neuroblastoma cells overexpressing either wild type APP695 (APPwt) or APP695V717F (APPmut). Both cell lines secrete higher levels of Aβ1-40 and Aβ1-42 compared to the parental line. In addition, APPmut produces more Aβ1-42 than APPwt. Whereas the basal levels of UPR markers are not different, we find augmented UPR induction in response to ER stress in both APP overproducing cell lines compared to the parental cell line, with the strongest UPR activation in APPmut cells. In addition, ER stress toxicity was highest in APPmut cells, strongly suggesting a connection with the production of Aβ1-42. The difference in ER stress mediated toxicity between the APPwt and APPmut cell lines is alleviated by pretreatment with γ-secretase inhibitor, indicating that it is dependent on Aβ production and in particular on Aβ1-42. Our data indicate that increased Aβ1-42 production sensitizes neuroblastoma cells for ER stress toxicity.
Export Options
About this article
Cite this article as:
Chafekar M. Sidhartha, Zwart Rob, Veerhuis Robert, Vanderstichele H., Baas Frank and Scheper Wiep, Increased Aβ1-42 Production Sensitizes Neuroblastoma Cells for ER Stress Toxicity, Current Alzheimer Research 2008; 5 (5) . https://dx.doi.org/10.2174/156720508785908883
DOI https://dx.doi.org/10.2174/156720508785908883 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
Call for Papers in Thematic Issues
New Advances in the Prevention, Diagnosis, Treatment, and Rehabilitation of Alzheimer's Disease
Aims and Scope: Introduction: Alzheimer's disease (AD) poses a significant global health challenge, with an increasing prevalence that demands concerted efforts to advance our understanding and strategies for prevention, diagnosis, treatment, and rehabilitation. This thematic issue aims to bring together cutting-edge research and innovative approaches from multidisciplinary perspectives to address ...read more
Current updates on the Role of Neuroinflammation in Neurodegenerative Disorders
Neuroinflammation is an invariable hallmark of chronic and acute neurodegenerative disorders and has long been considered a potential drug target for Alzheimer?s disease (AD) and dementia. Significant evidence of inflammatory processes as a feature of AD is provided by the presence of inflammatory markers in plasma, CSF and postmortem brain ...read more
Deep Learning for Advancing Alzheimer's Disease Research
Alzheimer's disease (AD) poses a significant global health challenge, with an increasing number of individuals affected yearly. Deep learning, a subfield of artificial intelligence, has shown immense potential in various domains, including healthcare. This thematic issue of Current Alzheimer Research explores the application of deep learning techniques in advancing our ...read more
Diagnostic and therapeutic biomarkers of dementia
Dementia affects 18 million people worldwide. Dementia is a syndrome of symptoms caused by brain disease, usually chronic or progressive, clinically characterized by multiple impairments of higher cortical functions such as memory, thinking, orientation, and learning. In addition, in the course of dementia, cognitive deficits are observed, which often hinder ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Canopy Fibroblast Growth Factor Signaling Regulator 2 (CNPY2) Inhibits Neuron Apoptosis in Parkinson’s Disease via the AKT/GSK3β Pathway
Current Neurovascular Research The Pro-Apoptotic Substance Thapsigargin Selectively Stimulates Re-Growth of Brain Capillaries
Current Neurovascular Research Defensins and Other Biocidal Proteins from Bean Seeds with Medicinal Activities
Current Medicinal Chemistry Nucleic Acid Aptamers Against Protein Kinases
Current Medicinal Chemistry Gene Expression Abnormalities in Thymoma
Current Pharmacogenomics Perturbation of HSP Network in MCF-7 Breast Cancer Cell Line Triggers Inducible HSP70 Expression and Leads to Tumor Suppression
Anti-Cancer Agents in Medicinal Chemistry Fusogenic Oncolytic Herpes Simplex Viruses as a Potent and Personalized Cancer Vaccine
Current Pharmaceutical Biotechnology Cancer Therapy By Targeting Hypoxia-Inducible Factor-1
Current Cancer Drug Targets Transcriptionally Targeted Adenovirus Vectors
Current Gene Therapy A Key Role for Connexin Hemichannels in Spreading Ischemic Brain Injury
Current Drug Targets Heat Shock Proteins as Prognostic Markers of Cancer
Current Cancer Drug Targets Medicinal Chemistry Insights into Novel HDAC Inhibitors: An Updated Patent Review (2012-2016)
Recent Patents on Anti-Cancer Drug Discovery Peptide Receptor Radionuclide Therapy with Somatostatin Analogues in Neuroendocrine Tumors
Anti-Cancer Agents in Medicinal Chemistry Studies on Target Genes of General Anesthetics-Version 2
Medicinal Chemistry Reviews - Online (Discontinued) Progress of HDAC Inhibitor Panobinostat in the Treatment of Cancer
Current Drug Targets Plant and Animal Steroids a New Hope to Search for Antiviral Agents
Current Medicinal Chemistry Identification of Prognostic Biomarkers in Papillary Thyroid Cancer and Developing Non-Invasive Diagnostic Models Through Integrated Bioinformatics Analysis
MicroRNA New Medical Strategies for Midgut Carcinoids
Anti-Cancer Agents in Medicinal Chemistry Rationale for the Development of Cholinesterase Inhibitors as Anti- Alzheimer Agents
Current Pharmaceutical Design Multi-Nuclear Platinum Drugs: A New Paradigm in Chemotherapy
Current Medicinal Chemistry - Anti-Cancer Agents